Financhill
Back

Esquire Financial Holdings Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
23

ESQ
Esquire Financial Holdings

Last Price:
46.55
Seasonality Move:
3.61%
Sell
44

RARE
Ultragenyx Pharmaceutical

Last Price:
41.49
Seasonality Move:
-0.9%
Sell
23
Esquire Financial Holdings (ESQ) is a Sell

Is Esquire Financial Holdings a Buy, Sell or Hold?

  • The current Esquire Financial Holdings [ESQ] share price is $46.05. The Score for ESQ is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • ESQ is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $40.50. The Score for RARE is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ESQ Stock Price Chart

What is Esquire Financial Holdings's stock price today?

  • The Esquire Financial Holdings share price today is $46.05
    The current trend is relatively stagnant and ESQ is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $40.50
    The current trend is relatively stagnant and RARE is experiencing slight buying pressure.

ESQ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.48 Sell
Relative Strength Index (14 RSI): 47.22 Sell
Chaikin Money Flow: 13796 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (45.47 - 47.01) Sell
Bollinger Bands (100): (46.01 - 49.33) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.6 Sell
Relative Strength Index (14 RSI): 49.22 Sell
Chaikin Money Flow: 494801 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.79 - 41.97) Buy
Bollinger Bands (100): (40.81 - 48.79) Sell

ESQ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.59 Buy
20-day SMA: 45.98 Buy
50-day SMA: 47.09 Sell
200-day SMA: 47.47 Sell
8-day EMA: 45.73 Buy
20-day EMA: 46.16 Sell
50-day EMA: 46.83 Sell
200-day EMA: 46.95 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.2 Buy
20-day SMA: 40.42 Buy
50-day SMA: 41.53 Sell
200-day SMA: 42.45 Sell
8-day EMA: 39.89 Buy
20-day EMA: 40.39 Buy
50-day EMA: 41.79 Sell
200-day EMA: 43.35 Sell

Esquire Financial Holdings Earnings Growth & ESQ Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, an increase next quarter of $0.08 per share, an increase this year of $0.35 per share, and an increase next year of $0.51 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.

Esquire Financial Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):